Cargando…
A tissue engineering strategy for the treatment of avascular necrosis of the femoral head
BACKGROUND & PURPOSE: Skeletal stem cells (SSCs) and impaction bone grafting (IBG) can be combined to produce a mechanically stable living bone composite. This novel strategy has been translated to the treatment of avascular necrosis of the femoral head. Surgical technique, clinical follow-up an...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Publications Office, The Royal College of Surgeons of Edinburgh
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989057/ https://www.ncbi.nlm.nih.gov/pubmed/23540814 http://dx.doi.org/10.1016/j.surge.2013.02.008 |
_version_ | 1782312114029854720 |
---|---|
author | Aarvold, A. Smith, J.O. Tayton, E.R. Jones, A.M.H. Dawson, J.I. Lanham, S. Briscoe, A. Dunlop, D.G. Oreffo, R.O.C. |
author_facet | Aarvold, A. Smith, J.O. Tayton, E.R. Jones, A.M.H. Dawson, J.I. Lanham, S. Briscoe, A. Dunlop, D.G. Oreffo, R.O.C. |
author_sort | Aarvold, A. |
collection | PubMed |
description | BACKGROUND & PURPOSE: Skeletal stem cells (SSCs) and impaction bone grafting (IBG) can be combined to produce a mechanically stable living bone composite. This novel strategy has been translated to the treatment of avascular necrosis of the femoral head. Surgical technique, clinical follow-up and retrieval analysis data of this translational case series is presented. METHODS: SSCs and milled allograft were impacted into necrotic bone in five femoral heads of four patients. Cell viability was confirmed by parallel in vitro culture of the cell-graft constructs. Patient follow-up was by serial clinical and radiological examination. Tissue engineered bone was retrieved from two retrieved femoral heads and was analysed by histology, microcomputed tomography (μCT) and mechanical testing. RESULTS: Three patients remain asymptomatic at 22- to 44-month follow-up. One patient (both hips) required total hip replacement due to widespread residual necrosis. Retrieved tissue engineered bone demonstrated a mature trabecular micro-architecture histologically and on μCT. Bone density and axial compression strength were comparable to trabecular bone. CONCLUSIONS: Clinical follow-up shows this to be an effective new treatment for focal early stage avascular necrosis of the femoral head. Unique retrieval analysis of clinically translated tissue engineered bone has demonstrated regeneration of tissue that is both structurally and functionally analogous to normal trabecular bone. |
format | Online Article Text |
id | pubmed-3989057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Publications Office, The Royal College of Surgeons of Edinburgh |
record_format | MEDLINE/PubMed |
spelling | pubmed-39890572014-04-17 A tissue engineering strategy for the treatment of avascular necrosis of the femoral head Aarvold, A. Smith, J.O. Tayton, E.R. Jones, A.M.H. Dawson, J.I. Lanham, S. Briscoe, A. Dunlop, D.G. Oreffo, R.O.C. Surgeon Article BACKGROUND & PURPOSE: Skeletal stem cells (SSCs) and impaction bone grafting (IBG) can be combined to produce a mechanically stable living bone composite. This novel strategy has been translated to the treatment of avascular necrosis of the femoral head. Surgical technique, clinical follow-up and retrieval analysis data of this translational case series is presented. METHODS: SSCs and milled allograft were impacted into necrotic bone in five femoral heads of four patients. Cell viability was confirmed by parallel in vitro culture of the cell-graft constructs. Patient follow-up was by serial clinical and radiological examination. Tissue engineered bone was retrieved from two retrieved femoral heads and was analysed by histology, microcomputed tomography (μCT) and mechanical testing. RESULTS: Three patients remain asymptomatic at 22- to 44-month follow-up. One patient (both hips) required total hip replacement due to widespread residual necrosis. Retrieved tissue engineered bone demonstrated a mature trabecular micro-architecture histologically and on μCT. Bone density and axial compression strength were comparable to trabecular bone. CONCLUSIONS: Clinical follow-up shows this to be an effective new treatment for focal early stage avascular necrosis of the femoral head. Unique retrieval analysis of clinically translated tissue engineered bone has demonstrated regeneration of tissue that is both structurally and functionally analogous to normal trabecular bone. Publications Office, The Royal College of Surgeons of Edinburgh 2013-12 /pmc/articles/PMC3989057/ /pubmed/23540814 http://dx.doi.org/10.1016/j.surge.2013.02.008 Text en © 2013 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Aarvold, A. Smith, J.O. Tayton, E.R. Jones, A.M.H. Dawson, J.I. Lanham, S. Briscoe, A. Dunlop, D.G. Oreffo, R.O.C. A tissue engineering strategy for the treatment of avascular necrosis of the femoral head |
title | A tissue engineering strategy for the treatment of avascular necrosis of the femoral head |
title_full | A tissue engineering strategy for the treatment of avascular necrosis of the femoral head |
title_fullStr | A tissue engineering strategy for the treatment of avascular necrosis of the femoral head |
title_full_unstemmed | A tissue engineering strategy for the treatment of avascular necrosis of the femoral head |
title_short | A tissue engineering strategy for the treatment of avascular necrosis of the femoral head |
title_sort | tissue engineering strategy for the treatment of avascular necrosis of the femoral head |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989057/ https://www.ncbi.nlm.nih.gov/pubmed/23540814 http://dx.doi.org/10.1016/j.surge.2013.02.008 |
work_keys_str_mv | AT aarvolda atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT smithjo atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT taytoner atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT jonesamh atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT dawsonji atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT lanhams atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT briscoea atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT dunlopdg atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT orefforoc atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT aarvolda tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT smithjo tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT taytoner tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT jonesamh tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT dawsonji tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT lanhams tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT briscoea tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT dunlopdg tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead AT orefforoc tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead |